Taken together with previous findings, the present study suggests that blocking VEGF signalling with bevacizumab inhibits vessel sprouting by reducing the expression of key mediators of the NOTCH signalling cascade, which may induce an angiogenic dormant tumour phenotype. Here, VEGFA is linked to neoplasm.